We previously discovered a common 2,903-base pair (bp) deletion polymorphism in the BIM gene that contributed to response heterogeneity in patients with CML and epidermal growth factor receptor-mutated non-small cell lung cancer (EGFR-NSCLC). This evidence concerns the gene BCL2L11 and non-small cell lung carcinoma.